Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: A retrospective cohort study

QJM: An International Journal of Medicine

Volumn 103, Issue 2, 2009, Pages 109-115

  Nihtyanova, S I ^a   Tang, E C ^a   Coghlan, J G ^a   Wells, A U ^b   Black, C M ^a   Denton, C P ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOBLOTTING; IMMUNOELECTROPHORESIS; IMMUNOFLUORESCENCE; LUNG ARTERY PRESSURE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SCLERODERMA; SCREENING TEST; SURVIVAL; SYSTEMIC SCLEROSIS;

EID: 77950261786     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcp174     Document Type: Article

References (18)

1. UK Scleroderma Study Group. How can treatment of systemic sclerosis be improved? By setting up a national database of all cases and entering patients into trials. BMJ 1998; 317:294-5.
2. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009; 179:151-7.
3. Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 2006; 54:3962-70.
4. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006; 354:2655-66.
5. Renzoni EA. Interstitial lung disease in systemic sclerosis (review). Monaldi Arch Chest Dis 2007; 67:217-28.
6. National Pulmonary Hypertension Centres of the UK and Ireland. Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Heart 2008; 94 (Suppl. 1): 11-41.
7. Penn H, Denton CP. Diagnosis, management and prevention of scleroderma renal disease (review). Curr Opin Rheumatol 2008; 20:692-6.
8. Allanore Y, Meune C, Kahan A. Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies (review). Curr Opin Rheumatol 2008; 20:697-702.
9. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007; 66:940-4.
10. Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 2008.
11. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients (review). Medicine 2002; 81:139-53.
12. Rawlins M. De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet 2008; 372:2152-61.
13. Williams MH, Das C, Handler CE, Akram MR, Davar J, Denton CP, et al. Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart 2006; 92:926-32.
14. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.
15. Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 1990; 113:352-7.
16. Shand L, Lunt M, Nihtyanova S, Hoseini M, Silman A, Black CM, et al. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model. 2007; 56:2422-31.
17. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52:3792-800.
18. Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 2007; 100:485-94.